P080: Universal germline testing of breast cancer as standard of care in a diverse, rural community oncology practice: The UNITY trial
Abstract
Universal germline genetic testing (GGT) of patients with breast cancer is of increasing importance for therapeutics, clinical trial enrollment, prevention of future cancers, and testing of at-risk family members. There is limited data on universal GGT in patients with breast cancer, especially in historically underrepresented and underserved populations receiving care at community practices. We present an interim analysis of 250 unselected patients with breast cancer who received GGT at a rural community oncology practice.
Fields of Study & Subjects
BRCA gene mutations in cancer
Breast Lesions and Carcinomas
Breast Cancer Treatment Studies
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 103571–103571
- Publication date
- 1 January 2026
- Language
- EN